On Sale!

2022 Lumenis OptiLIGHT M22 Dry Eye IPL System

Original price was: $21,500.00.Current price is: $12,750.00.

The 2022 Lumenis OptiLIGHT M22 is a professional IPL dry eye treatment system designed to improve Meibomian Gland Dysfunction (MGD) using advanced OPT pulse technology and ophthalmology-specific treatment protocols.

Delivery and return
Delivery and return
Shipping Information
Shipping Information
Composition and care
Composition and care

Description

2022 Lumenis OptiLIGHT M22 Dry Eye IPL System

The 2022 Lumenis OptiLIGHT M22 Dry Eye IPL System is an advanced Intense Pulsed Light (IPL) platform specifically designed for the treatment of dry eye disease associated with Meibomian Gland Dysfunction (MGD). Developed by Lumenis, the OptiLIGHT M22 combines proprietary Optimal Pulse Technology (OPT) with ophthalmology-focused treatment protocols to deliver safe, precise, and clinically effective dry eye management.

As one of the first IPL systems specifically approved for MGD-related dry eye treatment in several markets, the OptiLIGHT platform has become increasingly popular among ophthalmology clinics, dry eye centers, and medical aesthetic practices worldwide.

What Is the Lumenis OptiLIGHT M22?

Advanced IPL Technology for Dry Eye Treatment

The OptiLIGHT M22 is a specialized IPL system designed to improve tear film stability and reduce inflammation associated with dry eye disease.

Unlike standard cosmetic IPL devices, the OptiLIGHT system integrates ophthalmic-specific treatment settings and optimized pulse delivery for periocular treatment areas.

How OptiLIGHT Works

Meibomian Gland Dysfunction (MGD) Treatment

The system uses controlled IPL energy to:

  • Reduce inflammatory mediators
  • Improve meibomian gland function
  • Liquefy obstructed oils
  • Enhance tear film quality
  • Reduce ocular redness and irritation

Optimal Pulse Technology (OPT)

OPT technology ensures consistent energy delivery throughout every pulse, improving treatment safety and comfort.

Key Features

Ophthalmology-Specific IPL Platform

The 2022 model includes dedicated dry eye treatment protocols specifically engineered for ophthalmic use.

Benefits Include

  • Preset treatment parameters
  • Improved patient comfort
  • Simplified workflow
  • Consistent treatment results
  • Faster clinical procedures

SapphireCool Contact Cooling

The integrated SapphireCool cooling technology improves patient comfort during treatment while helping protect surrounding skin tissue.

Fast Treatment Sessions

Each treatment session typically requires approximately 10–15 minutes, making it highly suitable for busy ophthalmology clinics.

Specifications

Specification Category Details
Product Name Lumenis OptiLIGHT M22
Manufacturer Lumenis
System Type Intense Pulsed Light (IPL) Dry Eye Treatment System
Model Year 2022
Platform M22 Modular Multi-Application Platform
Primary Application Dry Eye Disease & MGD Treatment
Technology Intense Pulsed Light (IPL)
Pulse Technology Optimal Pulse Technology (OPT)
Cooling Technology SapphireCool Contact Cooling
Treatment Area Periocular Region
Intended Use Meibomian Gland Dysfunction (MGD)
Wavelength Range 515–1200 nm
Standard Filter 590 nm
Optional Filters 515 nm, 560 nm, 615 nm, 640 nm, 695 nm
Light Guide Sizes Small 8 × 15 mm
Large 15 × 35 mm
Maximum Fluence Up to 35 J/cm²
Pulse Delivery Uniform Pulse Output
Display Type Color Touchscreen Interface
Handpiece Type IPL Ophthalmic Handpiece
Treatment Duration Approximately 10–15 Minutes
Treatment Protocol Preset Ophthalmology Protocols
Patient Downtime Minimal
Clinical Workflow Fast Multi-Session Procedure
Number of Recommended Sessions Commonly 4 Sessions
Cooling Method Integrated Contact Cooling
System Mobility Portable Cart-Based Platform
Clinical Specialty Ophthalmology
Additional Platform Compatibility Aesthetic & Dermatology Modules
Optional Modules ResurFX, Universal IPL, Nd:YAG
Energy Control Adjustable Fluence Settings
Skin Type Compatibility Multiple Fitzpatrick Skin Types
Safety Features Controlled Pulse Energy & Cooling
Regulatory Classification Medical IPL System
User Interface Guided Treatment Workflow
Procedure Type Non-Invasive
Maintenance Manufacturer Preventive Maintenance Recommended
Typical Users Ophthalmologists, Dry Eye Clinics, Eye Centers
Common Indications Dry Eye, MGD, Ocular Rosacea
Power Requirements Medical Electrical Standard
Country of Manufacturer Israel

 

Reviews

There are no reviews yet.

Be the first to review “2022 Lumenis OptiLIGHT M22 Dry Eye IPL System”